Dr SG Vasantharaju

Associate Professor - Senior Scale

Date of Joining: 29.12.2006

Department of Pharmaceutical Quality Assurance

CURRENT ACADEMIC ROLE & RESPONSIBILITIES

    SG Vasantharaju conducts theory and practical classes for BPharmacy and MPharmacy students.
    He:

    • Guides students in their thesis work.
    • Conducts seminars for post graduate students.
    • Is resource person for staff development programs and faculty development program.

SUBJECTS CURRENTLY TEACHING

Subject Semester / Year
Pharmaceutical Analysis Theory Third year PharmD
Pharmaceutical Analysis lab Third year Pharm.D
Modern Pharmaceutical Analytical Techniques MPharm First semester
Pharmaceutical Quality Assurance practicals-I MPharm- First semester

ACADEMIC QUALIFICATIONS

Degree Specialisation Institute Year of passing
BPharm (Bachelor of Pharmacy) National College of Pharmacy, Shimoga 1992
MPharm Pharmaceutical Chemistry Birla Institute of Technology, Mesra, Ranchi 1995
Ph.D. Pharmaceutical Sciences 沙巴体育 College of Pharmaceutical Sciences, 沙巴体育 Academy of Higher Education 2012

Experience

Institution / Organisation Designation Role Tenure
Department of Pharmaceutical Quality Assurance, MCOPS, 沙巴体育 Academy of Higher Education Associate Professor
Department of Pharmaceutical Quality Assurance, MCOPS, 沙巴体育 Academy of Higher Education Selection Grade Lecturer 2009-2012
Department of Pharmaceutical Quality Assurance, MCOPS, 沙巴体育 Academy of Higher Education Senior Grade Lecturer 2007-2009
Valley College of Pharmacy, J C Nagar , Bangalore Lecturer 1992 - 1993
Bapuji Pharmacy College, Davangere Lecturer and Senior Lecturer 1995-2006

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Expertise

Synthesis of new chemical entities and their preclinical evaluation of antidiabetic and antihyperlipidemic drugs belongs to Thaizolidin-4-ones, Analytical and bioanalytical method development and validation for drug substances and drug products

Professional Affiliations & Contributions

?? Derivatives of Thaizolidin-4-one new drug molecules showed a good antidiabetic and anti hyperlypidemic activity from previous studies. I selected these molecules and synthesized several derivatives of this, characterized by modern spectroscopic and chromatographic techniques. These new chemical entities tested for in-vitro antidiabetic activities. The compounds showed promising activities by in-vitro are tested in animals for antidiabetic and anti hyperlypidemic activity in detail. The works have been well presented in national and international pharmacy conferences. The works also published in indexed, high impact factor international journals like Bioorganic and Medicinal Chemistry, Chemico-Biological Interactions, Journal of Diabetes and BioMed 沙巴体育 沙巴体育.? ? ?

?? Guided several post graduate students of pharmacy for the analysis of drugs in API, formulation and body fluids by sophisticated instruments like HPLC, HPTLC, LC-MS/MS. Several of these works have presented in in national and international pharmacy conferences. The works also published in indexed, high impact factor national and international journals like Journal of Planar Chromatography, Arzneimittelforschung, INDIAN DRUGS, Indian Journal of Pharmaceutical Sciences, Indian Journal of Pharmaceutical Education and 沙巴体育 etc.??

?? Published several research papers in reputed national and international journals with H index of 2.5 and an average impact factor for international journals of 1.350.

Received best research paper award from Association of Pharmaceutical Teachers of Inidia in 2014 for research paper published in Indian Journal of Pharmaceutical Education and 沙巴体育.

The author credentials and citation graphs can be accessed by following platforms

ORCID ID: orcid.org/0000-0002-2024-7292

Scopus author ID: 26029233800

Peer review record can be verified at:

PUBLON ID: https://publons.com/author/736622/vasantharaju-s-g#profile

Life Member of Association of Pharmaceutical Teachers of India, 1997. ?

Synthesis, Characterization, and Preclinical Evaluation of New Thiazolidin-4-Ones Substituted with p-Chlorophenoxy Acetic Acid and Clofibric Acid against Insulin Resistance and Metabolic Disorder

SG Vasantharaju Jayesh Mudgal Punit Bansal Pawan G. Nayak Seethappa A. Manohara Reddy Gautham Shenoy G Manna Valiathan C Mallikarjuna Rao

BioMed 沙巴体育, Vol. 14, (2014), Impact factor: 2.800

Determination of Lamotrigine and Felbamate in Pediatric Plasma Samples by Reverse Phase HPLC.

Sumit Kumar Jain SG Vasantharaju Raghavendra Shetty Naresh Bejugam Syed Sajjad Hussen Krishnamurthy Bhat

Indian Journal of Pharmaceutical Education and 沙巴体育, Vol. 47, (2013), Impact Factor: 0.150

Development of a Sensitive Bioanalytical Method for the Quantification of Lacosamide in Rat Plasma. Application to Preclinical Pharmacokinetics Studies in Rats

S. Shah SG Vasantharaju K. Arumugam Muddukrishna Badamane Sathyanarayana N. Desai

Arzneimittelforschung, Vol. 62, (2012), Impact Factor: 0.690

Antioxidant, anti-inflammatory and anti-hyperglycemic activities of heterocyclic homoprostanoid derivatives.

S.A. Manohar Reddy Jayesh Mudgal Punit Bansal SG Vasantharaju K.K. Srinivasan C Mallikarjuna Rao

Bioorganic and Medicinal Chemistry, Vol. 19, (2011), Impact factor: 2.903

Remedial effects of novel 2,3-disubstituted thiazolidin-4-ones in chemical mediated inflammation.

Jayesh Mudgal SG Vasantharaju Geetha Mathew Pawan G. Nayak Nitin D. Reddy Neelesh Namdeo Ravilla R. Kumar Chaitanya Kantamaneni C Mallikarjuna Rao

Chemico-Biological Interactions, Vol. 210, (2014), Impact factor: 2.970

Stability Indicating Assay Method Development and Validation For The Simultaneous Estimation Of Metformin Hydrochloride And Canagliflozin In Bulk Drug By RP-HPLC.

Ms. Sonia D'souza

MPharm Part-II (2016)

Analytical Method Development and Validation for Total Iron and Ascorbic acid in Ferrous Bisglycinate Effervescent Tablets by Colorimetry and RP-HPLC.

Ms. A. Srivalli

MPharm Part-II (2016)

Sensitive Analytical Method Development and Validation For Ciprofloxacin By RP-HPLC- An Application to Sample Cleaning Analysis

Mr. Jovyan D'silva

MPharm Part-II (2016)